ACH-1625

Achillion May Be The Most Underrated Biotech Left
Seeking Alpha
Wed, 06/26/13 - 09:35 am
Achillion
AbbVie
Bristol-Myers Squibb
Gilead
Vertex Pharmaceuticals
Indenix
ACH-3102
ACH-1625
hepatitis C
Invest in the Great Progress of Hepatitis C
Motley Fool
Sat, 12/8/12 - 11:17 am
hepatitis C
Gilead Sciences
sofosbuvir
Medivir
TMC435
ACH-1625
Achillion
Does Achillion Have a Place in the HCV Market of the Future?
Yahoo/Reuters
Wed, 11/14/12 - 12:30 pm
Achillion
hepatitis C
Abbott Labs
Gilead
ACH-1625
Vertex Pharmaceuticals
Achillion Back On The Hep C Roller Coaster Of Love
Seeking Alpha
Wed, 09/19/12 - 11:30 am
Achillion
hepatitis C
Abbott Labs
Gilead
JNJ
Merck
Pfizer
ACH-1625
5 Biotech Stocks That Could Soar On New Hepatitis C Drugs
Seeking Alpha
Sat, 04/21/12 - 12:17 pm
Vertex
Incivek
ABT-072
ABT-450
Abbott Laboratories
Achillion
ACH-1625
ACH-2684
ACH-2928
ACH-3102
TMC435
JNJ
GSK
hepatitis C
Achillion Announces 94 - 100% Complete EVR From Phase 2 Trial With ACH-1625 Based Regimen in Hepatitis C
Yahoo/Globe NewsWire
Sat, 04/21/12 - 12:05 pm
Achillion
ACH-1625
ACH-3102
ACH-2928
hepatitis C
Achillion: A Compelling 'Buy' Candidate Now
Motley Fool
Mon, 04/16/12 - 11:51 am
Achillion
ACH-1625
ACH-2684
ACH-2928
Watch Achillion Pharmaceutical For Upcoming Phase IIa Data
Forex Pros
Sun, 04/8/12 - 12:44 pm
Achillion
ACH-1625
HCV
hepatitis C
Watch Achillion Pharmaceuticals For Upcoming Phase IIa Data
Seeking Alpha
Wed, 04/4/12 - 08:30 am
Achillion
hepatitis C
ACH-1625
Achillion's hepatitis C drug gets FDA fast track
Reuters
Wed, 01/4/12 - 09:25 am
Achillion
fast track
FDA
hepatitis C
ACH-1625